Delivery Order SPE2DB22D1017-SPE2DB24FG3AJ

Award Date 8/12/24
Potential Completion Date 8/13/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of VIMPAT 200 MG TABLET 60S, a pharmaceutical product. The $2,501.60 firm-fixed-price contract has a completion date of September 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these prescription medication tablets under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,438.46 firm fixed-price delivery order is for the supply of VIMPAT 100 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of December 18, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VIMPAT 150 MG tablets. The delivery order, valued at $1,240.24, is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award, valued at $1,678.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIMPAT 100 MG TABLET 60S, a pharmaceutical product, with an ultimate completion date of May 16, 2025. The contract is a Delivery Order under a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition....
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,598.25 firm fixed-price delivery order is for VIMPAT 200 MG TABLET UD 60S, a pharmaceutical product, with a period of performance through June 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $1,759.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIMPAT 100 MG TABLET 60S, a pharmaceutical product, to the government. The contract has a completion date of May 7, 2025 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,320.52 firm-fixed-price delivery order is for the supply of VIMPAT 150 MG tablets. The contract has an ultimate completion date of August 17, 2022 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,682.43, is for the supply of VIMPAT 100 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of February 20, 2025. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,138.98 firm fixed-price delivery order covers the supply of VIMPAT 150 MG TABLET 60S, with a period of performance through January 9, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIMPAT 200 MG TABLET 60S, a prescription medication, with a ceiling value of $3,318.54 and a completion date of August 8, 2022. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a set-aside requirement, indicating it was awarded...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG3AJ
    Delivery Order

This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,117.65 firm fixed-price contract is for the supply of VIMPAT 50 mg tablets. This order is under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA, valued up to $999,999,999 through December 2025, for providing a wide range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside designation and the ultimate completion date is August 13, 2024. As a leading pharmaceutical distributor, AmerisourceBergen leverages its extensive supply chain to deliver critical prescription medications, medical supplies, and equipment to various federal healthcare providers and agencies.

Generated 11/11/24, 9:13 AM